CTLT
Price:
$63.48
Market Cap:
$11.52B
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. It operates through four segments: Biologics, Softgel and Oral Technologies, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products, such as prescription drugs, over-the-counter medications, dietary supplements, unit-dose cosmetics, and animal health medicinal preparations. The Biologics segment provides biologic cell-line; develops and manufactur...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2014-07-31
Stock Exchange
NYSE
Ticker
CTLT
According to Catalent, Inc.’s latest financial reports and current stock price. The company's current ROE is -11.44%. This represents a change of 301.73% compared to the average of -2.85% of the last 4 quarters.
The mean historical ROE of Catalent, Inc. over the last ten years is 7.94%. The current -11.44% ROE has changed -244.02% with respect to the historical average. Over the past ten years (40 quarters), CTLT's ROE was at its highest in in the June 2015 quarter at 24.24%. The ROE was at its lowest in in the September 2023 quarter at -18.31%.
Average
7.94%
Median
9.29%
Minimum
-28.94%
Maximum
33.47%
Discovering the peaks and valleys of Catalent, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 478.18%
Maximum Annual ROE = 33.47%
Minimum Annual Increase = -868.16%
Minimum Annual ROE = -28.94%
Year | ROE | Change |
---|---|---|
2024 | -28.94% | 478.18% |
2023 | -5.01% | -148.10% |
2022 | 10.41% | -30.36% |
2021 | 14.94% | 150.38% |
2020 | 5.97% | -26.96% |
2019 | 8.17% | 6.21% |
2018 | 7.69% | -49.31% |
2017 | 15.18% | -13.45% |
2016 | 17.53% | -47.61% |
2015 | 33.47% | -868.16% |
The current ROE of Catalent, Inc. (CTLT) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-7.85%
5-year avg
-0.53%
10-year avg
7.94%
Catalent, Inc.’s ROE is less than IQVIA Holdings Inc. (21.50%), less than West Pharmaceutical Services, Inc. (18.35%), less than Charles River Laboratories International, Inc. (11.21%), greater than Bio-Rad Laboratories, Inc. (-9.72%), less than Teleflex Incorporated (5.28%),
Company | ROE | Market cap |
---|---|---|
21.50% | $36.14B | |
18.35% | $23.87B | |
11.21% | $9.48B | |
-9.72% | $9.20B | |
5.28% | $8.28B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Catalent, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Catalent, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Catalent, Inc.'s ROE?
How is the ROE calculated for Catalent, Inc. (CTLT)?
What is the highest ROE for Catalent, Inc. (CTLT)?
What is the 3-year average ROE for Catalent, Inc. (CTLT)?
What is the 5-year average ROE for Catalent, Inc. (CTLT)?
How does the current ROE for Catalent, Inc. (CTLT) compare to its historical average?